1. Protein Tyrosine Kinase/RTK
  2. FAK
  3. PND-1186

PND-1186 (Synonyms: SR-2516; VS-4718)

Cat. No.: HY-13917 Purity: 99.71%
Handling Instructions

PND-1186 is a potent and reversible inhibitor of FAK with an IC50 of 1.5 nM in cell assay.

For research use only. We do not sell to patients.

PND-1186 Chemical Structure

PND-1186 Chemical Structure

CAS No. : 1061353-68-1

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in DMSO USD 146 In-stock
Estimated Time of Arrival: December 31
5 mg USD 132 In-stock
Estimated Time of Arrival: December 31
10 mg USD 180 In-stock
Estimated Time of Arrival: December 31
50 mg USD 420 In-stock
Estimated Time of Arrival: December 31
100 mg USD 660 In-stock
Estimated Time of Arrival: December 31
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Customer Review

Based on 5 publication(s) in Google Scholar

Top Publications Citing Use of Products

    PND-1186 purchased from MCE. Usage Cited in: Cancer Cell. 2019 Mar 18;35(3):457-472.e5.

    Immunoblot showing YAP nuclear and cytoplasmic localization after 2 h VS-4718 (1 mM) treatment in OMM1.3 cells, using lamin A/C and a-tubulin as nuclear and cytoplasmic markers, respectively.

    PND-1186 purchased from MCE. Usage Cited in: Cancer Cell. 2019 Mar 18;35(3):457-472.e5.

    Immunoblot showing the association of MOB1 with LATS1 after HA or pY immunoprecipitation of OMM1.3 cells transfected with HA-MOB1 with or without 1 h VS-4718 treatment.
    • Biological Activity

    • Protocol

    • Technical Information

    • Purity & Documentation

    • References

    Description

    PND-1186 is a potent and reversible inhibitor of FAK with an IC50 of 1.5 nM in cell assay.

    IC50 & Target

    IC50: 1.5 nM (FAK)[1]

    In Vitro

    Using the recombinant FAK kinase domain as a glutathione-S-transferase (GST) fusion protein in an in vitro kinase assay, PND-1186 inhibits FAK activity with IC50 of 1.5 nM. PND-1186 has an IC50 of ~100 nM in breast carcinoma cells as determined by anti-phospho-specific immunoblotting to FAK Tyr-397. Whereas 1.0 µM PND-1186 (>5-fold above IC50) has limited effects on cell proliferation, under non-adherent conditions or when grown as spheroids or colonies in soft agar, 0.1 µM PND-1186 blocks FAK and p130Cas tyrosine phosphorylation, promotes caspase-3 activation, and triggers cell apoptosis. PND-1186 inhibits 4T1 breast carcinoma subcutaneous tumor growth correlated with elevated tumor cell apoptosis and caspase 3 activation[1].

    In Vivo

    100 mg/kg PND-1186 treatment significantly reduces final 4T1 tumor weight 2-fold (n=8, p<0.05) whereas 30 mg/kg PND-1186 slightly reduces final tumor weight but is not significantly different compare to control (n=8, p>0.05). Both 30 and 100 mg/kg administration of PND-1186 significantly increases tumor TUNEL staining compare to vehicle-treated controls. As elevated cleaved caspase-3 staining is also found in the tumors of PND-1186-treated mice[1]. PND-1186 displays a multi-exponential decay with a terminal half life (t1/2) of 1.72 hours after i.v. injection. Following i.p. and p.o. dosing, PND-1186 is rapidly absorbed with terminal half lives (t1/2) of 2.15 to 2.65 h, and bioavailability (%F) from 14.8 to 42.2%. PND-1186 bioavailability is greater upon intraperitoneal versus oral dosing[2].

    Clinical Trial
    Storage
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    DMSO : ≥ 34 mg/mL (67.80 mM)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.9940 mL 9.9701 mL 19.9402 mL
    5 mM 0.3988 mL 1.9940 mL 3.9880 mL
    10 mM 0.1994 mL 0.9970 mL 1.9940 mL
    *Please refer to the solubility information to select the appropriate solvent.
    References
    Cell Assay
    [1]

    For cell growth analyses, adherent or suspended cells are treated with PND-1186 for the indicated times, collected as a single cell suspension by limited trypsin treatment, fixed with 70% ethanol, collected by centrifugation and washed with PBS. Cell pellets are resuspended in 300 µL of PBS containing propidium iodide (PI) (10 µg/mL), DNAse-free RNAse (100 µg/mL), and then incubated at 37°C with agitation for 1 h. Samples are analyzed by flow cytometry and cell cycle analyses are performed by ModFit LT3.2 software. Hypodiploid DNA content as a measure of cell apoptosis is detected by PI staining. For cell apoptosis analyses, adherent or suspended cells are treated with PND-1186 and collected as above, stained for phycoerythrin (PE)-conjugated annexin V binding and 7-amino-actinomycin (7-AAD) reactivity, and analyzed within 1 h by flow cytometry. Quadrant gates are positioned based on cell autofluorescence (negative) staurosporine-treated (positive) controls. Apoptosis is calculated to be the percent of annexin V-positive cells. In the soft agar assays, apoptosis is quantified by visual inspection of at least 200 cells and is defined as the appearance of membrane blebbing or cell shrinkage. Apoptosis is also detected by appearance of cleaved caspase-3 antibody reactivity in protein lysates by immunoblotting[1].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [1]

    Mice[1]
    Six to eight week old female C57BL6 and BALB/c mice are used. For subcutaneous tumor growth, 1×106 mCherry-labeled 4T1 cells in 100 µL PBS are injected into the hindflank of Balb/C mice. After 8 days, mice with equal volume tumors (as measured using vernier calipers and determined by length×width2/2) are grouped (n=8 per group) and PND-1186 solubilized in polyethylene glycol 400 (PEG400) in PBS (1:1) is injected (100 µL) subcutaneously in the neck region at 30 mg/kg or 100 mg/kg every 12 hours. Control animals receive PEG400:PBS injections and at 13 days, tumors are imaged in situ using an Olympus OV100 Intravital Fluorescence Molecular Imaging System, tumors are excised and weighed, half is frozen in OCT, and half is solubilized in protein lysis buffer for FAK phosphorylation analyses.

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References
    Molecular Weight

    501.50

    Formula

    C₂₅H₂₆F₃N₅O₃

    CAS No.

    1061353-68-1

    SMILES

    O=C(NC)C1=CC=CC=C1NC2=CC(NC3=CC=C(N4CCOCC4)C=C3OC)=NC=C2C(F)(F)F

    Shipping

    Room temperature in continental US; may vary elsewhere

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product name

     

    Salutation

    Applicant name *

     

    Email address *

    Phone number *

     

    Organization name *

    Country or Region *

     

    Requested quantity *

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    PND-1186
    Cat. No.:
    HY-13917
    Quantity:

    PND-1186

    Cat. No.: HY-13917